“FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Efficacy and Safety From a Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study” (2018) SKIN The Journal of Cutaneous Medicine, 2, p. S56. doi:10.25251/skin.2.supp.56.